ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
Abstract Deletion of ABL1 was detected in a cohort of hematologic malignancies carrying AML1-ETO and NUP98 fusion proteins. Abl1−/− murine hematopoietic cells transduced with AML1-ETO and NUP98-PMX1 gained proliferation advantage when compared to Abl1 + /+ counterparts. Conversely, overexpression an...
Main Authors: | Konstantin Golovine, Gleb Abalakov, Zhaorui Lian, Srinivas Chatla, Adam Karami, Kumaraswamy Naidu Chitrala, Jozef Madzo, Margaret Nieborowska-Skorska, Jian Huang, Tomasz Skorski |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-03-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-023-00810-0 |
Similar Items
-
Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor
by: Margaret Nieborowska-Skorska, et al.
Published: (2019-12-01) -
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
by: Sagarajit Mohanty
Published: (2023-07-01) -
Clonal composition of karyotypically normal AML at diagnosis is not affected by the microenvironment
by: Monika M. Toma, et al.
Published: (2025-05-01) -
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
by: Li Liu, et al.
Published: (2024-07-01) -
The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
by: Milad Rasouli, et al.
Published: (2023-08-01)